Abstract
We present a case of a patient undergoing aortic valve replacement being inadvertently administered 5000 U of bovine thrombin instead of heparin for anticoagulation for cardiopulmonary bypass. The labeling error was made within the operating room pharmacy. The key to survival of this patient was a rapid diagnosis, administration of antithrombin and heparin, and removal of cardiac and great vessel thrombi. It is recommended that point of care anesthesia providers `prepare heparin for cardiopulmonary bypass anticoagulation, as thrombin is not used in anesthetic practice and is not contained within anesthesia cabinet medication drawers.
Similar content being viewed by others
References
Beso A, Franklin BD, Barber N (2005) The frequency and potential causes of dispensing errors in a hospital pharmacy. Pharm World Sci 27:182–190
James KL, Barlow D, McArtney R, Hiom S, Roberts D, Whittlesea C (2009) Incidence, type and causes of dispensing errors: a review of the literature. Int J Pharm Pract 17:9–30
Santell JP (2006) Technological methods used to prevent errors aren’t infallible. Mater Manag Health Care 15:26–28
Hanna GM, Levine WC (2011) Medication safety in the perioperative setting. Anesthesiol Clin 29:135–144
Uchigasaki S, Takahashi H, Suzuki T (1998) A case of delayed death after accidental intravenous injection of thrombin. Int J Legal Med 111:202–204
Acknowledgments
There was no funding for this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that there are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Nielsen, V.G., Paidy, S.R., Meek, C.A. et al. Survival after intravenous thrombin prior to cardiopulmonary bypass. Int J Legal Med 131, 485–487 (2017). https://doi.org/10.1007/s00414-016-1480-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-016-1480-7